Personalized estimates of breast cancer risk in clinical practice and public health
- PMID: 21337591
- PMCID: PMC3079423
- DOI: 10.1002/sim.4187
Personalized estimates of breast cancer risk in clinical practice and public health
Abstract
This paper defines absolute risk and some of its properties, and presents applications in breast cancer counseling and prevention. For counseling, estimates of absolute risk give useful perspective and can be used in management decisions that require weighing risks and benefits, such as whether or not to take tamoxifen to prevent breast cancer. Absolute risk models are also useful in designing intervention trials to prevent breast cancer and in assessing the potential reductions in absolute risk of disease that might result from reducing exposures that are associated with breast cancer. In these applications, it is important that the risk model be well calibrated, namely that it accurately predicts the numbers of women who will develop breast cancer in various subsets of the population. Absolute risk models are also needed to implement a 'high risk' prevention strategy that identifies a high-risk subset of the population and focuses intervention efforts on that subset. The limitations of the high-risk strategy are discussed, including the need for risk models with high discriminatory accuracy, and the need for less toxic interventions that can reduce the threshold of risk above which the intervention provides a net benefit. I also discuss the potential use of risk models in allocating prevention resources under cost constraints. High discriminatory accuracy of the risk model, in addition to good calibration, is desirable in this application, and the risk assessment should not be expensive in comparison with the intervention.
This article is a U.S. Government work and is in the public domain in the U.S.A. Published in 2011 by John Wiley & Sons, Ltd.
Figures
Similar articles
-
Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening.J Natl Cancer Inst. 2018 Sep 1;110(9):994-1002. doi: 10.1093/jnci/djy013. J Natl Cancer Inst. 2018. PMID: 29490057 Free PMC article.
-
Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.J Natl Cancer Inst. 2001 Mar 7;93(5):358-66. doi: 10.1093/jnci/93.5.358. J Natl Cancer Inst. 2001. PMID: 11238697
-
Projecting individualized absolute invasive breast cancer risk in African American women.J Natl Cancer Inst. 2007 Dec 5;99(23):1782-92. doi: 10.1093/jnci/djm223. Epub 2007 Nov 27. J Natl Cancer Inst. 2007. PMID: 18042936
-
Assessing women at high risk of breast cancer: a review of risk assessment models.J Natl Cancer Inst. 2010 May 19;102(10):680-91. doi: 10.1093/jnci/djq088. Epub 2010 Apr 28. J Natl Cancer Inst. 2010. PMID: 20427433 Review.
-
Digital Breast Tomosynthesis with Hologic 3D Mammography Selenia Dimensions System for Use in Breast Cancer Screening: A Single Technology Assessment [Internet].Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Sep 4. Report from the Norwegian Institute of Public Health No. 2017-08. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Sep 4. Report from the Norwegian Institute of Public Health No. 2017-08. PMID: 29553669 Free Books & Documents. Review.
Cited by
-
Polygenic Risk Score, Environmental Tobacco Smoke, and Risk of Lung Adenocarcinoma in Never-Smoking Women in Taiwan.JAMA Netw Open. 2023 Nov 1;6(11):e2339254. doi: 10.1001/jamanetworkopen.2023.39254. JAMA Netw Open. 2023. PMID: 37955902 Free PMC article.
-
Deep Learning Analysis of Mammography for Breast Cancer Risk Prediction in Asian Women.Diagnostics (Basel). 2023 Jul 3;13(13):2247. doi: 10.3390/diagnostics13132247. Diagnostics (Basel). 2023. PMID: 37443642 Free PMC article.
-
Will Absolute Risk Estimation for Time to Next Screen Work for an Asian Mammography Screening Population?Cancers (Basel). 2023 Apr 29;15(9):2559. doi: 10.3390/cancers15092559. Cancers (Basel). 2023. PMID: 37174025 Free PMC article.
-
Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan.Cancer Epidemiol Biomarkers Prev. 2022 Dec 5;31(12):2208-2218. doi: 10.1158/1055-9965.EPI-22-0281. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 36129788 Free PMC article.
-
Curcumin inhibits the growth of triple-negative breast cancer cells by silencing EZH2 and restoring DLC1 expression.J Cell Mol Med. 2020 Sep;24(18):10648-10662. doi: 10.1111/jcmm.15683. Epub 2020 Jul 28. J Cell Mol Med. 2020. PMID: 32725802 Free PMC article.
References
-
- Rose GA. The Strategy of Preventive Medicine. Oxford University Press; Oxford: 1992.
-
- Feero WG, Guttmacher AE, Collins FS. The genome gets personal -Almost. Jama-Journal of the American Medical Association. 2008;299:1351–1352. - PubMed
-
- Pharoah PDP, Antoniou AC, Easton DF, Ponder BAJ. Polygenes, risk prediction, and targeted prevention of breast cancer. New England Journal of Medicine. 2008;358:2796–2803. - PubMed
-
- Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. Journal of the National Cancer Institute. 2001;93:358–366. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical